Purchase this article with an account.
Andres Uriostegui Rojas, Deisy Diarte, Maria Jose Salgado Canseco, Miguel Pedroza-Seres; Herpetic uveitis and its association with secondary glaucoma and/or ocular hypertension in the Instituto de Oftalmología "Fundación Conde de Valenciana" in the period 2010-2015.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3746.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To describe the incidence of secondary glaucoma and/or ocular hypertension in patients with herpetic uveitis, as well as its therapeutic management in third level ophthalmologic center in Mexico.
A period of five years was analyzed through a database of patients that were seen in our uvea service from January 2010 to December 2015, with the diagnosis of herpetic uveitis (herpes simplex or varicela-zoster). Patients with 6 months follow-up of were included. Patients who did not follow up or who stopped medical treatment were excluded.
We studied 264 patients with herpetic uveitis diagnosis and its association with secondary glaucoma or ocular hypertension; Only 14% (37 patients) of the total of patients developed secondary glaucoma and 18% (47 patients) developed ocular hypertension. Of the 14% of patients with uveitis glaucoma, 80% required treatment with an Ahmed valve implant (29 patients), versus 4% (9 patients) only medical treatment (hypotensive monotherapy); 47 patients (18%) who o whom developed ocular hypertension were treated with beta-blocker monotherapy. Regarding intraocular pressure, in the secondary glaucoma group the mean pre-treatment intraocular pressure was 31mmHg, the intraocular pressure after treatment was 12mmHg; in the ocular hypertension group the pre-treatment intraocular pressure was 24 mmHg; The intraocular pressure after treatment was 11 mmHg.
Herpetic uveitis is one of the most common pathologies in Ophthalmology and Ophthalmologic Emergency service therefore the importance of an early diagnosis that could avoid complications such as uveitis and/or ocular hypertension.
This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.
This PDF is available to Subscribers Only